Phase 0 4 trials
Phase 0
NCT06598332 Aug 2025 → May 2028 acute graft versus host disease Baylor College of Medicine
Withdrawn
No outcome recorded
Stop: Business
Phase 0
NCT04958486 Jul 2021 → Sep 2023 posterior fossa ependymoma The University of Texas Health Science Center, Houston
Completed
No outcome recorded
Phase 0
NCT04187703 Nov 2020 → Nov 2026 expected myelodysplastic syndrome , myelodysplastic/myeloproliferative neoplasm Benjamin Tomlinson
Recruiting
No outcome recorded
Phase 0
NCT02940483 Feb 2017 → Nov 2018 brain cancer The University of Texas Health Science Center, Houston
Completed
No outcome recorded
Phase 1 5 trials
Phase 1
NCT06377085 Jul 2025 → Dec 2026 expected cerebral palsy Shirley Ryan AbilityLab
Enrolling by invitation
No outcome recorded
Phase 1
NCT06466798 Jul 2024 → Jul 2027 central nervous system cancer , ependymoma , medulloblastoma Jeffrey Treiber
Withdrawn
No outcome recorded
Phase 1
NCT03572530 Feb 2019 → Nov 2020 ependymoma The University of Texas Health Science Center, Houston
Completed
No outcome recorded
Phase 1
NCT03206021 Aug 2017 → Aug 2022 central nervous system cancer , childhood ependymoma , childhood malignant neoplasm The Hospital for Sick Children
Completed
No outcome recorded
Phase 1
NCT00996515 Jun 2008 → Jul 2011 high grade malignant neoplasm New Mexico Cancer Research Alliance
Completed
No outcome recorded
Phase 1/2 6 trials
Phase 1/2
NCT03825367 Nov 2019 → May 2023 childhood acute myeloid leukemia Therapeutic Advances in Childhood Leukemia Consortium
Unknown
No outcome recorded
Phase 1/2
NCT02829840 Sep 2016 → Sep 2021 acute myeloid leukemia M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1/2
NCT02096042 Apr 2014 → Aug 2016 leukemia M.D. Anderson Cancer Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT01202877 Mar 2011 → Jul 2015 leukemia M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT00946647 Dec 2009 → Apr 2019 acute myeloid leukemia , chronic myelomonocytic leukemia , myelodysplastic syndrome Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 1/2
NCT01038635 Dec 2009 → Nov 2015 leukemia M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2 14 trials · 1 missed
Phase 2
NCT07522801 Sep 2026 → Dec 2029 expected —
Philippe ROUSSELOT
Not yet recruiting
No outcome recorded
Phase 2
NCT05317000 Mar 2023 → Jun 2028 expected head and neck squamous cell carcinoma Barbara Burtness
Recruiting
No outcome recorded
Phase 2
NCT02204020 Apr 2015 acute myeloid leukemia , myelodysplastic syndrome University of Pittsburgh
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 2
NCT02497404 Feb 2015 → Jun 2020 acute erythroid leukemia , myelodysplastic syndrome Weill Medical College of Cornell University
Completed
No outcome recorded
Phase 2
NCT02124174 Jan 2012 → Jan 2022 acute myeloid leukemia , myelodysplastic syndrome Patrick Stiff
Unknown
No outcome recorded
Phase 2
NCT01053806 Aug 2011 → Mar 2014 myelodysplastic syndrome Tel-Aviv Sourasky Medical Center
Unknown
No outcome recorded
Phase 2
NCT00997243 Nov 2009 → Sep 2010 leukemia , myelodysplastic syndrome Alison Walker
Terminated
No outcome recorded
Phase 2
NCT00704704 Sep 2008 → Sep 2010 myelodysplastic syndrome Tel-Aviv Sourasky Medical Center
Unknown
No outcome recorded
Phase 2
NCT00721214 Jul 2008 → Jun 2014 myelodysplastic syndrome Virginia Commonwealth University
Completed
No outcome recorded
Phase 2
NCT00439673 May 2007 → Jul 2010 myelodysplastic syndrome GIMEMA Foundation
Completed
No outcome recorded
Phase 2
NCT00413478 Sep 2006 → Nov 2014 B-cell chronic lymphocytic leukemia M.D. Anderson Cancer Center
Terminated
Missed primary
Stop: Enrollment
Phase 2
NCT00339196 Jul 2006 → Jul 2008 acute myeloid leukemia , myelodysplastic syndrome Assistance Publique - Hôpitaux de Paris
Completed
No outcome recorded
Phase 2
NCT00326170 Jul 2005 → Jul 2007 acute myeloid leukemia , myelodysplastic syndrome M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT00005934 Jun 2000 → Jun 2003 beta-thalassemia major National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
No outcome recorded
Show 4 more trials Comparator or background therapy 2 trials
Phase 1
NCT03612739 Background Dec 2018 → May 2019 acute myeloid leukemia , myelodysplastic syndrome Celyad Oncology SA
Withdrawn
No outcome recorded
Stop: Business
Phase 2
NCT00382590 Comparator Aug 2005 → Feb 2008 acute myeloid leukemia , myelodysplastic syndrome M.D. Anderson Cancer Center
Completed
No outcome recorded